These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 33375448)

  • 21. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders.
    Bauer M; Alda M; Priller J; Young LT;
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S250-4. PubMed ID: 14677087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity.
    Guttuso T
    Med Hypotheses; 2019 Oct; 131():109302. PubMed ID: 31443765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge.
    Ikonomov OC; Manji HK
    Am J Psychiatry; 1999 Oct; 156(10):1506-14. PubMed ID: 10518159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis.
    Machado-Vieira R; Manji HK; Zarate CA
    Bipolar Disord; 2009 Jun; 11 Suppl 2(Suppl 2):92-109. PubMed ID: 19538689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
    Machado-Vieira R
    J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lithium and Therapeutic Targeting of GSK-3.
    Snitow ME; Bhansali RS; Klein PS
    Cells; 2021 Jan; 10(2):. PubMed ID: 33525562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does lithium prevent Alzheimer's disease?
    Forlenza OV; de Paula VJ; Machado-Vieira R; Diniz BS; Gattaz WF
    Drugs Aging; 2012 May; 29(5):335-42. PubMed ID: 22500970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posttranslational modifications & lithium's therapeutic effect-Potential biomarkers for clinical responses in psychiatric & neurodegenerative disorders.
    Khayachi A; Schorova L; Alda M; Rouleau GA; Milnerwood AJ
    Neurosci Biobehav Rev; 2021 Aug; 127():424-445. PubMed ID: 33971223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?
    Chuang DM
    Crit Rev Neurobiol; 2004; 16(1-2):83-90. PubMed ID: 15581403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lithium, a potential protective drug in Alzheimer's disease.
    Engel T; Goñi-Oliver P; Gómez de Barreda E; Lucas JJ; Hernández F; Avila J
    Neurodegener Dis; 2008; 5(3-4):247-9. PubMed ID: 18322403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inositol and IP3 levels regulate autophagy: biology and therapeutic speculations.
    Sarkar S; Rubinsztein DC
    Autophagy; 2006; 2(2):132-4. PubMed ID: 16874097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.
    Atack JR; Broughton HB; Pollack SJ
    Trends Neurosci; 1995 Aug; 18(8):343-9. PubMed ID: 7482796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective effects of SB-415286 on hydrogen peroxide-induced cell death in B65 rat neuroblastoma cells and neurons.
    Pizarro JG; Yeste-Velasco M; Rimbau V; Casadesús G; Smith MA; Pallàs M; Folch J; Camins A
    Int J Dev Neurosci; 2008; 26(3-4):269-76. PubMed ID: 18342477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks.
    Padiath QS; Paranjpe D; Jain S; Sharma VK
    Chronobiol Int; 2004 Jan; 21(1):43-55. PubMed ID: 15129823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the Neuroprotective Effects of Lithium in Ischemic Stroke: A literature review.
    Wang W; Lu D; Shi Y; Wang Y
    Int J Med Sci; 2024; 21(2):284-298. PubMed ID: 38169754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing.
    Su Y; Ryder J; Li B; Wu X; Fox N; Solenberg P; Brune K; Paul S; Zhou Y; Liu F; Ni B
    Biochemistry; 2004 Jun; 43(22):6899-908. PubMed ID: 15170327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new avenue for lithium: intervention in traumatic brain injury.
    Leeds PR; Yu F; Wang Z; Chiu CT; Zhang Y; Leng Y; Linares GR; Chuang DM
    ACS Chem Neurosci; 2014 Jun; 5(6):422-33. PubMed ID: 24697257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
    Lipton SA
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.
    Gould TD; Manji HK
    Neuropsychopharmacology; 2005 Jul; 30(7):1223-37. PubMed ID: 15827567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional changes in rat brain inositol monophosphatase 1 (IMPase 1) activity with chronic lithium treatment.
    Parthasarathy LK; Seelan RS; Wilson MA; Vadnal RE; Parthasarathy RN
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):55-60. PubMed ID: 12551726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.